These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 10436424

  • 41. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM, Sauermann P, Werner M, Schuessler B, Blick N, Muentener M, Strebel RT, Perucchini D, Scheiner D, Schaer G, John H, Reitz A, Hauri D, Schurch B.
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [Abstract] [Full Text] [Related]

  • 42. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
    Kim Y, Yoshimura N, Masuda H, de Miguel F, Chancellor MB.
    Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029
    [Abstract] [Full Text] [Related]

  • 43. [Clinical effects of oxybutynin hydrochloride on neurogenic bladder].
    Toma H, Nakamura R.
    Hinyokika Kiyo; 1986 Jun; 32(6):907-11. PubMed ID: 3532726
    [Abstract] [Full Text] [Related]

  • 44. Topical oxybutynin chloride for relaxation of dysfunctional bladders.
    Brendler CB, Radebaugh LC, Mohler JL.
    J Urol; 1989 Jun; 141(6):1350-2. PubMed ID: 2724432
    [Abstract] [Full Text] [Related]

  • 45. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Tapp AJ, Cardozo LD, Versi E, Cooper D.
    Br J Obstet Gynaecol; 1990 Jun; 97(6):521-6. PubMed ID: 2198921
    [Abstract] [Full Text] [Related]

  • 46. Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial.
    Malone-Lee J, Shaffu B, Anand C, Powell C.
    J Urol; 2001 May; 165(5):1452-6. PubMed ID: 11342895
    [Abstract] [Full Text] [Related]

  • 47. Tolterodine: a clinical review.
    Crandall C.
    J Womens Health Gend Based Med; 2001 Oct; 10(8):735-43. PubMed ID: 11703885
    [Abstract] [Full Text] [Related]

  • 48. Idiopathic bladder hyperactivity treated with Ditropan (oxybutynin chloride).
    Nagy F, Hamvas A, Frang D.
    Int Urol Nephrol; 1990 Oct; 22(6):519-24. PubMed ID: 2093692
    [Abstract] [Full Text] [Related]

  • 49. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
    Yucel S, Akkaya E, Guntekin E, Kukul E, Danisman A, Akman S, Baykara M.
    Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
    [Abstract] [Full Text] [Related]

  • 50. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
    Franco I, Horowitz M, Grady R, Adams RC, de Jong TP, Lindert K, Albrecht D.
    J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
    [Abstract] [Full Text] [Related]

  • 51. Reduction of urgency severity is associated with long-term therapeutic effect after intravesical onabotulinumtoxin A injection for idiopathic detrusor overactivity.
    Kuo HC.
    Neurourol Urodyn; 2011 Nov; 30(8):1497-502. PubMed ID: 21717501
    [Abstract] [Full Text] [Related]

  • 52. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
    Zellner M, Madersbacher H, Palmtag H, Stöhrer M, Bödeker RH, P195 Study Group.
    Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
    [Abstract] [Full Text] [Related]

  • 53. Treatment of detrusor instability with oxybutynin rectal suppositories.
    Winkler HA, Sand PK.
    Int Urogynecol J Pelvic Floor Dysfunct; 1998 Nov; 9(2):100-2. PubMed ID: 9694139
    [Abstract] [Full Text] [Related]

  • 54. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
    Mizunaga M, Miyata M, Kaneko S, Yachiku S, Chiba K.
    Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
    [Abstract] [Full Text] [Related]

  • 55. [Experimental studies of urinary incontinence. Effect of tiropramide on the urinary stage and evacuation].
    Morita T, Ando M, Hirano S, Dokita S, Kondo S, Tsuchida S.
    Nihon Hinyokika Gakkai Zasshi; 1992 Nov; 83(11):1835-40. PubMed ID: 1336080
    [Abstract] [Full Text] [Related]

  • 56. Bladder-sphincter biofeedback as treatment of detrusor instability in women who failed to respond to oxybutynin.
    Wang AC.
    Chang Gung Med J; 2000 Oct; 23(10):590-9. PubMed ID: 11126150
    [Abstract] [Full Text] [Related]

  • 57. Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.
    Zát'ura F, Vsetica J, Abadías M, Pavlík I, Schraml P, Brod'ák M, Villoria J, Sust M, E-4018/CL50 Study Group.
    Eur Urol; 2010 Jan; 57(1):145-52. PubMed ID: 19446951
    [Abstract] [Full Text] [Related]

  • 58. Detrusorectomy reduces the need for augmentation and use of antimuscarinics in children with neuropathic bladders.
    Chrzan R, Dik P, Klijn AJ, Kuijper CF, de Jong TP.
    J Pediatr Urol; 2013 Apr; 9(2):193-8. PubMed ID: 22364713
    [Abstract] [Full Text] [Related]

  • 59. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
    Reitz A, Stöhrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, Burgdörfer H, Göcking K, Madersbacher H, Schumacher S, Richter R, von Tobel J, Schurch B.
    Eur Urol; 2004 Apr; 45(4):510-5. PubMed ID: 15041117
    [Abstract] [Full Text] [Related]

  • 60. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
    Staskin DR, Te AE.
    BJU Int; 2006 Jun; 97(6):1256-61. PubMed ID: 16686722
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.